Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemias
US11547696B2 · kind B2 · utility
1Cited by
10References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2017 |
| Grant date | Jan 10, 2023 |
| Priority date | — |
| Expiry date | Sep 11, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for treating a myelodyspastic syndrome (MDS) and/or an acute myeloid leukemia (AML) in an individual in need thereof. Further disclosed are compositions for use in the disclosed methods, used for treating a myelodyspastic syndrome (MDS) and/or an acute myeloid leukemia (AML) in an individual in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.